Shierley Widjaja

McKinley Capital Management LLC (McKinley Capital) is a SEC-registered investment headquartered in Anchorage, Alaska. The firm was founded by Robert “Bob” Gillam in 1990 and is wholly-owned by McKinley Management, Inc. McKinley Capital provides investment advisory and sub-advisory services to institutional, individual and high-net worth investors. They also participate as a sub-advisor in various wrap fee programs and provide emulation or model portfolios to clients. In addition, the firm is the general partner and/or investment advisor to various commingled investment funds such as offshore and onshore limited partnerships and a statutory trust.

Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA .

Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA.